Miglustat as Disease-Modifying Therapy in a Patient with SCARB2-Related Action Myoclonus Renal Failure.

IF 2.6 4区医学 Q2 CLINICAL NEUROLOGY

Movement Disorders Clinical Practice Pub Date : 2024-11-08 DOI:10.1002/mdc3.14273

Fabiana Colucci, Andrea Dardis, Eleonora Pavan, Maurizio Scarpa, Andrea Gozzi, Pietro Antenucci, Marianna Farnè, Marcella Neri, Alessandra Ferlini, Valeria Tugnoli, Annalisa Sechi, Mariachiara Sensi

引用次数: 0

查看原文本刊更多论文

米格鲁司特作为疾病调节疗法用于一名 SCARB2 相关性肌阵挛肾衰竭患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Movement Disorders Clinical Practice CLINICAL NEUROLOGY-

CiteScore

4.00

自引率

7.50%

发文量

218

期刊介绍： Movement Disorders Clinical Practice- is an online-only journal committed to publishing high quality peer reviewed articles related to clinical aspects of movement disorders which broadly include phenomenology (interesting case/case series/rarities), investigative (for e.g- genetics, imaging), translational (phenotype-genotype or other) and treatment aspects (clinical guidelines, diagnostic and treatment algorithms)